Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)—a European cohort study

BackgroundPTEN hamartoma tumour syndrome (PHTS) patients have a high hereditary risk of cancer, especially breast (BC), endometrial (EC), and thyroid cancer (TC). However, the prognosis of PHTS-related cancers is unknown.MethodsThis European cohort study included adult PHTS patients with data from m...

ver descrição completa

Detalhes bibliográficos
Autores: Hendricks, Linda A. J., Verbeek, Katja C. J., Schuurs Hoeijmakers, Janneke H.M., Putter, Robin de, Brems, Hilde, Daele, Sien H. van, Anastasiadou, Violetta C., Foretova, Lenka, Benusiglio, Patrick R., Gerasimenko, Anna, Colas, Chrystelle, Villy, Marie Charlotte, Houdayer, Claude, Branchaud, Maud, Hüneburg, Robert, Aretz, Stefan, Jahn, Arne, Steinke-Lange, Verena, Innella, Giovanni, Turchetti, Daniela, Barili, Valeria, Genuardi, Maurizio, Panfili, Arianna, Baldassarri, Margherita, Irmejs, Arvids, Jong, Mirjam M. de, Links, Thera P., Leter, Edward M., Bosch, Daniëlle G.M., Donze, Stephany H., Post, Rachel S. van der, Mensenkamp, Arjen R., Westdorp, Harm, Høberg-Vetti, Hildegunn, Tveit Haavind, Marianne, Jørgensen, Kjersti, Mæhle, Lovise, Briskemyr, Siri, Dupont Garcia, Juliette, Blatnik, Ana, Balmaña, Judith, Torres, Maite, Brunet, Joan, Lleuger Pujol, Roser, Tham, Emma, Tischkowitz, Marc, Evans, D.Gareth, Hyder, Zerin, Hoogerbrugge, Nicoline, Vos, Janet R.
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Recursos:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/223666
Acesso em linha:https://hdl.handle.net/2445/223666
Access Level:acceso abierto
Palavra-chave:Oncologia pediàtrica
Càncer d'ovari
Oncologia
Tumors in children
Ovarian cancer
Oncology
id ES_3fcf75a8da392ffe9dffae6dcf283dba
oai_identifier_str oai:recercat.cat:2445/223666
network_acronym_str ES
network_name_str España
repository_id_str
spelling Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)—a European cohort studyHendricks, Linda A. J.Verbeek, Katja C. J.Schuurs Hoeijmakers, Janneke H.M.Putter, Robin deBrems, HildeDaele, Sien H. vanAnastasiadou, Violetta C.Foretova, LenkaBenusiglio, Patrick R.Gerasimenko, AnnaColas, ChrystelleVilly, Marie CharlotteHoudayer, ClaudeBranchaud, MaudHüneburg, RobertAretz, StefanJahn, ArneSteinke-Lange, VerenaInnella, GiovanniTurchetti, DanielaBarili, ValeriaGenuardi, MaurizioPanfili, AriannaBaldassarri, MargheritaIrmejs, ArvidsJong, Mirjam M. deLinks, Thera P.Leter, Edward M.Bosch, Daniëlle G.M.Donze, Stephany H.Post, Rachel S. van derMensenkamp, Arjen R.Westdorp, HarmHøberg-Vetti, HildegunnTveit Haavind, MarianneJørgensen, KjerstiMæhle, LoviseBriskemyr, SiriDupont Garcia, JulietteBlatnik, AnaBalmaña, JudithTorres, MaiteBrunet, JoanLleuger Pujol, RoserTham, EmmaTischkowitz, MarcEvans, D.GarethHyder, ZerinHoogerbrugge, NicolineVos, Janet R.Oncologia pediàtricaCàncer d'ovariOncologiaTumors in childrenOvarian cancerOncologyBackgroundPTEN hamartoma tumour syndrome (PHTS) patients have a high hereditary risk of cancer, especially breast (BC), endometrial (EC), and thyroid cancer (TC). However, the prognosis of PHTS-related cancers is unknown.MethodsThis European cohort study included adult PHTS patients with data from medical files, registries, and/or questionnaires. Overall survival (OS) was assessed using Kaplan-Meier analyses and were compared with sporadic cancer and the general population using standardized mortality (SMR) and relative survival rates (RSR). Survival bias was addressed using left-truncation.ResultsOverall, 147 BC patients were included. The 10y-OS was 77% (95%CI = 66-90), decreasing with increasing stage from 90% (95%CI = 73-100) for stage 0 to 0% (95%CI = 0-0) for stage IV. BC relative survival was comparable to sporadic BC in the first two years (2y-RSR = 1.1; 95%CI = 1.1-1.1) and increasing thereafter (5y-RSR = 1.7; 95%CI = 1.6-1.7). For TC (N = 56) and EC (N = 35), 10y-OS was 87% (95%CI = 74-100) and 64% (95%CI = 38-100), respectively. Overall and cancer-specific mortality in female PHTS patients exceeded general population rates (SMR = 3.7; 95%CI = 2.6-5.0 and SMR = 2.7; 95%CI = 1.6-4.4).ConclusionsThe prognosis of PHTS-related cancers was comparable to the general population. The higher overall mortality in PHTS patients is presumably related to their higher cancer incidence. These findings, and the high survival observed in early-stage cancer, emphasise the importance of recognising PHTS early to facilitate cancer surveillance.Springer Science and Business Media LLC2025202520252025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion10 p.application/pdfhttps://hdl.handle.net/2445/223666Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésReproducció del document publicat a: https://doi.org/10.1038/s44276-025-00157-yBJC Reports, 2025, vol. 3, 42https://doi.org/10.1038/s44276-025-00157-ycc-by (c) Hendricks, Linda A. J. et al., 2025http://creativecommons.org/licenses/by/3.0/es/info:eu-repo/semantics/openAccessoai:recercat.cat:2445/2236662026-05-29T05:05:01Z
dc.title.none.fl_str_mv Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)—a European cohort study
title Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)—a European cohort study
spellingShingle Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)—a European cohort study
Hendricks, Linda A. J.
Oncologia pediàtrica
Càncer d'ovari
Oncologia
Tumors in children
Ovarian cancer
Oncology
title_short Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)—a European cohort study
title_full Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)—a European cohort study
title_fullStr Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)—a European cohort study
title_full_unstemmed Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)—a European cohort study
title_sort Cancer prognosis and treatment results in patients with PTEN Hamartoma Tumour Syndrome (PHTS)—a European cohort study
dc.creator.none.fl_str_mv Hendricks, Linda A. J.
Verbeek, Katja C. J.
Schuurs Hoeijmakers, Janneke H.M.
Putter, Robin de
Brems, Hilde
Daele, Sien H. van
Anastasiadou, Violetta C.
Foretova, Lenka
Benusiglio, Patrick R.
Gerasimenko, Anna
Colas, Chrystelle
Villy, Marie Charlotte
Houdayer, Claude
Branchaud, Maud
Hüneburg, Robert
Aretz, Stefan
Jahn, Arne
Steinke-Lange, Verena
Innella, Giovanni
Turchetti, Daniela
Barili, Valeria
Genuardi, Maurizio
Panfili, Arianna
Baldassarri, Margherita
Irmejs, Arvids
Jong, Mirjam M. de
Links, Thera P.
Leter, Edward M.
Bosch, Daniëlle G.M.
Donze, Stephany H.
Post, Rachel S. van der
Mensenkamp, Arjen R.
Westdorp, Harm
Høberg-Vetti, Hildegunn
Tveit Haavind, Marianne
Jørgensen, Kjersti
Mæhle, Lovise
Briskemyr, Siri
Dupont Garcia, Juliette
Blatnik, Ana
Balmaña, Judith
Torres, Maite
Brunet, Joan
Lleuger Pujol, Roser
Tham, Emma
Tischkowitz, Marc
Evans, D.Gareth
Hyder, Zerin
Hoogerbrugge, Nicoline
Vos, Janet R.
author Hendricks, Linda A. J.
author_facet Hendricks, Linda A. J.
Verbeek, Katja C. J.
Schuurs Hoeijmakers, Janneke H.M.
Putter, Robin de
Brems, Hilde
Daele, Sien H. van
Anastasiadou, Violetta C.
Foretova, Lenka
Benusiglio, Patrick R.
Gerasimenko, Anna
Colas, Chrystelle
Villy, Marie Charlotte
Houdayer, Claude
Branchaud, Maud
Hüneburg, Robert
Aretz, Stefan
Jahn, Arne
Steinke-Lange, Verena
Innella, Giovanni
Turchetti, Daniela
Barili, Valeria
Genuardi, Maurizio
Panfili, Arianna
Baldassarri, Margherita
Irmejs, Arvids
Jong, Mirjam M. de
Links, Thera P.
Leter, Edward M.
Bosch, Daniëlle G.M.
Donze, Stephany H.
Post, Rachel S. van der
Mensenkamp, Arjen R.
Westdorp, Harm
Høberg-Vetti, Hildegunn
Tveit Haavind, Marianne
Jørgensen, Kjersti
Mæhle, Lovise
Briskemyr, Siri
Dupont Garcia, Juliette
Blatnik, Ana
Balmaña, Judith
Torres, Maite
Brunet, Joan
Lleuger Pujol, Roser
Tham, Emma
Tischkowitz, Marc
Evans, D.Gareth
Hyder, Zerin
Hoogerbrugge, Nicoline
Vos, Janet R.
author_role author
author2 Verbeek, Katja C. J.
Schuurs Hoeijmakers, Janneke H.M.
Putter, Robin de
Brems, Hilde
Daele, Sien H. van
Anastasiadou, Violetta C.
Foretova, Lenka
Benusiglio, Patrick R.
Gerasimenko, Anna
Colas, Chrystelle
Villy, Marie Charlotte
Houdayer, Claude
Branchaud, Maud
Hüneburg, Robert
Aretz, Stefan
Jahn, Arne
Steinke-Lange, Verena
Innella, Giovanni
Turchetti, Daniela
Barili, Valeria
Genuardi, Maurizio
Panfili, Arianna
Baldassarri, Margherita
Irmejs, Arvids
Jong, Mirjam M. de
Links, Thera P.
Leter, Edward M.
Bosch, Daniëlle G.M.
Donze, Stephany H.
Post, Rachel S. van der
Mensenkamp, Arjen R.
Westdorp, Harm
Høberg-Vetti, Hildegunn
Tveit Haavind, Marianne
Jørgensen, Kjersti
Mæhle, Lovise
Briskemyr, Siri
Dupont Garcia, Juliette
Blatnik, Ana
Balmaña, Judith
Torres, Maite
Brunet, Joan
Lleuger Pujol, Roser
Tham, Emma
Tischkowitz, Marc
Evans, D.Gareth
Hyder, Zerin
Hoogerbrugge, Nicoline
Vos, Janet R.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Oncologia pediàtrica
Càncer d'ovari
Oncologia
Tumors in children
Ovarian cancer
Oncology
topic Oncologia pediàtrica
Càncer d'ovari
Oncologia
Tumors in children
Ovarian cancer
Oncology
description BackgroundPTEN hamartoma tumour syndrome (PHTS) patients have a high hereditary risk of cancer, especially breast (BC), endometrial (EC), and thyroid cancer (TC). However, the prognosis of PHTS-related cancers is unknown.MethodsThis European cohort study included adult PHTS patients with data from medical files, registries, and/or questionnaires. Overall survival (OS) was assessed using Kaplan-Meier analyses and were compared with sporadic cancer and the general population using standardized mortality (SMR) and relative survival rates (RSR). Survival bias was addressed using left-truncation.ResultsOverall, 147 BC patients were included. The 10y-OS was 77% (95%CI = 66-90), decreasing with increasing stage from 90% (95%CI = 73-100) for stage 0 to 0% (95%CI = 0-0) for stage IV. BC relative survival was comparable to sporadic BC in the first two years (2y-RSR = 1.1; 95%CI = 1.1-1.1) and increasing thereafter (5y-RSR = 1.7; 95%CI = 1.6-1.7). For TC (N = 56) and EC (N = 35), 10y-OS was 87% (95%CI = 74-100) and 64% (95%CI = 38-100), respectively. Overall and cancer-specific mortality in female PHTS patients exceeded general population rates (SMR = 3.7; 95%CI = 2.6-5.0 and SMR = 2.7; 95%CI = 1.6-4.4).ConclusionsThe prognosis of PHTS-related cancers was comparable to the general population. The higher overall mortality in PHTS patients is presumably related to their higher cancer incidence. These findings, and the high survival observed in early-stage cancer, emphasise the importance of recognising PHTS early to facilitate cancer surveillance.
publishDate 2025
dc.date.none.fl_str_mv 2025
2025
2025
2025
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/223666
url https://hdl.handle.net/2445/223666
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1038/s44276-025-00157-y
BJC Reports, 2025, vol. 3, 42
https://doi.org/10.1038/s44276-025-00157-y
dc.rights.none.fl_str_mv cc-by (c) Hendricks, Linda A. J. et al., 2025
http://creativecommons.org/licenses/by/3.0/es/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by (c) Hendricks, Linda A. J. et al., 2025
http://creativecommons.org/licenses/by/3.0/es/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 10 p.
application/pdf
dc.publisher.none.fl_str_mv Springer Science and Business Media LLC
publisher.none.fl_str_mv Springer Science and Business Media LLC
dc.source.none.fl_str_mv Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869406686184210432
score 15,811543